Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 78,744 $ 58,910
Prepaid expenses 2,535 1,485
Accounts receivable from related party 31,163 0
Other current assets 4,385 19
Total current assets 116,827 60,414
Property and equipment, net 7,165 1,952
In-process research and development 26,623 26,623
Other assets 1,345 1,402
Total assets 151,960 90,391
Current liabilities:    
Accounts payable 1,630 2,517
Accrued liabilities 6,595 2,690
Current portion of long-term debt 0 2,400
Deferred revenue 33,400 2,765
Other current liabilities 106 70
Total current liabilities 41,731 10,442
Warrant liabilities 38 954
Long-term debt, net 3,155 1,078
Other liabilities 844 628
Total liabilities 45,768 13,102
Commitments and contingencies (Note 9)
Stockholders’ equity    
Common stock, $0.001 par value, shares authorized: 150,000,000 shares; issued and outstanding: 36,496,116 shares at September 30, 2018 and 26,898,330 shares at December 31, 2017 36 27
Additional paid-in capital 194,226 141,733
Accumulated other comprehensive loss 0 0
Accumulated deficit (88,070) (64,471)
Total stockholders’ equity 106,192 77,289
Total liabilities and stockholders’ equity $ 151,960 $ 90,391